Skip to main content

Table 1 Characteristics of individual patients.

From: Treatment of esophageal tumors using high intensity intraluminal ultrasound: first clinical results

No.

Gender

Age

Tumor type

TNM stage

Stricture C/L/T

Number of US sessions

Other treatments

Dysphagia Improvement

M1 status

M3 status

Survival

1

M

80

SCC

T3N1M0

360°/30/6 180°/15/6

1

5FU/CDDP

5 > 1

PR Clin: good Obstructive nodule Stent require

No tumor progression Clin: good No dysphagia

>4 mo

2

M

55

SCC

T1N0

110°/10/7 360°/9/9

3

5FU/CDDP

3 > 0

CR, proximal tumorPR, distal tumorClin: goodNo dysphagia

PRClin: poor, deteriorating general conditionRecurrent dysphagia

6 mo

3

M

83

AC

T3N2M1

360°/30/12

1

5FU

5 > 2

  

3 wk

4

F

86

SCC

T3NxM0

360°/20/7–12

1

 

5 > 2

PRClin: poorWeight loss (2 kg)

 

3 mo

  1. SCC, squamous cell carcinoma; AC, adenocarcinoma; TNM, tumor, node, metastasis; C/L/T, circumference/length/thickness of tumor (mm); 5FU, fluorouracil; CDDP, cisplatinum; M1, M3, 1 and 3 months after treatment; clin, clinical status; PR, partial response; CR, complete response; US, ultrasound.